Hyvinkään sairaala on Helsingin ja Uudenmaan sairaanhoitopiirin kuuluva sairaala, joka sijaitsee Hyvinkään kaupungissa kolme kilometriä keskustasta lounaaseen. Hyvinkään sairaanhoitoalue palvelee noin 190 000 asukkaan väestöpohjaa ja käsittää viisi kuntaa: Hyvinkää, Järvenpää, Mäntsälä, Nurmijärvi ja Tuusula.

During the past decade, Hyvinkää Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hyvinkää Hospital" #1 sponsor was "Helsinki University Central Hospital" with 2 trials, followed by "Anna Meuronen, MD" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Jukka Putaala" with 1 trials sponsored and "Karolinska Institutet" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hyvinkää Hospital" #1 collaborator was "Hyvinkää Hospital" with 1 trials as a collaborator, "Investigators meetings supported by Gynecare Scandinavia." with 1 trials as a collaborator, "Jorvi Hospital" with 1 trials as a collaborator, "Peijas Hospital" with 1 trials as a collaborator and "The Swedish Society of Medicine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hyvinkää Hospital" are "Acute Abdomen" (1 trials), "Acute Pain Due to Trauma" (1 trials), "Atrial Fibrillation" (1 trials), "Empowerment" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Hyvinkää Hospital" in a lesser frequency.

Most popular intervention types in "Hyvinkää Hospital" are "Diagnostic Test" (2 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abdominal or body CT with intravenous contrast" (1 trials), "Abdominal or body CT without intravenous contrast (native CT)" (1 trials), "Anterior PROLIFT" (1 trials), "Anterior colporrhaphy" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hyvinkää Hospital" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hyvinkää Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hyvinkää Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hyvinkää Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".